Loading company
BriaCell Therapeutics Corp.
BCTX · Nasdaq · ·
Next earnings: October 21, 2026
$4.08+2.0%Sep 29 close
- 1M
- +9.4%
- 6M
- -1.2%
- 1Y
- -62.9%
- 5Y
- -99.7%
BriaCell Therapeutics Corp. is scheduled to report next on October 21, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
What BriaCell Therapeutics Corp. reported on October 28, 2022
The quarter ending April 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toApr 30, 2026 | 3 months toApr 30, 2025 | Change |
|---|---|---|---|
| Profit | -$7.2M | -$6.1M | -16.94% |
| Profit per share | -$0.99 | -$10.64 | +90.70% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Earnings calls
BriaCell Therapeutics Corp. has no earnings call transcript available.
How the share price reacted
Releases land after the close or before the open, so the move is the session that follows.
Close before
$814.50
Oct 28, 2022
Close after
$825.00
Oct 31, 2022
Move
+1.29%
0 shares traded, against a normal 0
The quote and the company description come from BriaCell Therapeutics Corp.’s Item 2.02 8-K filed October 28, 2022; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.